Synvista Therapeutics, Inc

On March 25, 2008, the Audit Committee of the Board of Directors of Synvista Therapeutics, Inc. named Wendy A. Milici, age 36, as the Company's principal financial officer. Ms. Milici joined Synvista in November 2004 and serves as the Company's director of finance and administration, responsible for preparing operating budgets and forecasts, coordinating the audit process, negotiating consulting agreements, confidential disclosure agreements and material transfer agreements, and preparing and coordinating the Company's filings with the Securities and Exchange Commission, among other responsibilities. Prior to joining Synvista, Ms. Milici was an audit administrator at AXA Financial, f/k/a The MONY Group, beginning in 1998, where she was responsible for the development of the company's budget and the preparation of audit committee materials